Faron Pharmaceuticals Oy (LON:FARN) Share Price Passes Below 50 Day Moving Average – Here’s Why

Faron Pharmaceuticals Oy (LON:FARN)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 208.38 ($2.71) and traded as low as GBX 161.28 ($2.09). Faron Pharmaceuticals Oy shares last traded at GBX 177.50 ($2.30), with a volume of 77,081 shares.

Faron Pharmaceuticals Oy Trading Up 2.5 %

The company has a quick ratio of 1.09, a current ratio of 1.45 and a debt-to-equity ratio of 922.55. The firm’s 50-day simple moving average is GBX 208.38 and its 200 day simple moving average is GBX 165.67. The stock has a market capitalization of £190.41 million, a P/E ratio of -554.69 and a beta of 0.36.

Faron Pharmaceuticals Oy Company Profile

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company’s lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.